Ongoing, recruitingHuman Pharmacology (Phase I)- OtherInterventional

A trial to investigate the effect of acalabrutinib on skin prick test wheal size in adults with grass pollen allergy

At a glance

Status

Ongoing, recruiting

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Alk-Abello A/S

Enrolment target

12

Start

19 Oct 2023

grass pollen allergy

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Germany

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.